Will Trump benefit India

India hopes to strategically win with the signing of a new US President's medical device order.

The new executive order signed by US President Donald Trump, which ensures that US government agencies get all the major medicines they need from American sources, will benefit India. Quoting government sources, WION said, "The objectives of these measures are primarily aimed at China." The US President's order on essential drugs "could strategically benefit India". In addressing Ohio workers, US President Trump stressed domestic production of "essential equipment, supplies and pharmaceuticals" so the US doesn't have to rely on others. China is the world's largest source of APIs, including India large quantities imported from the country. According to sources, the development of active ingredient and critical drug manufacturing in the US could be a positive development for India in terms of national safety considerations and as a source outside of China, India, which sent hydroxychloroquine (HCQ) to the US as part of the coronavirus pandemic, could be India , have a significant relationship with America in terms of pharmaceuticals. Indian pharmaceutical companies like Cipla, Sun Pharma, Dr. Reddy's and others are present in the US market. Read the full article in WION: